What stage does DCI Partners Co. Ltd. invest at?

DCI Partners Co. Ltd. invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth stages.

What is DCI Partners Co. Ltd.'s typical check size?

DCI Partners Co. Ltd. typically writes checks of $4.3M – $71M.

What sectors does DCI Partners Co. Ltd. focus on?

DCI Partners Co. Ltd. focuses on Biotech, Digital Health, Healthtech, Medical Devices, SaaS, Sector Agnostic.

Where is DCI Partners Co. Ltd. located?

DCI Partners Co. Ltd. is headquartered in Tokyo, JP.

DCI Partners Co. Ltd.

Venture capital

Tokyo · Pre-Seed–Growth · 4 people tracked

Also known as 大和企業投資株式会社

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

DCI Partners is a specialized VC focused on drug discovery and regenerative medicine, building on more than 20 years of biotech investing experience dating from its NIF era (now Daiwa Corporate Investment). It operates one of the largest specialized funds of its kind in Japan, supplying risk capital to growth-stage companies poised to shape future industries. Beyond funding, the firm offers hands-on support drawing on expertise in clinical development, intellectual property, and business development, plus networks across research institutions, drug-discovery ventures, and pharmaceutical companies. It also leads the creation of new ventures from promising research seeds and collaborates across Japan and Taiwan to maximize portfolio potential.

Invests inBiotech Digital Health Healthtech Medical Devices SaaS Sector AgnosticAsia-PacificJapanTaiwanTokyoUnited States

Source: firm website, verified Aug 3, 2026.

Stage

Pre-Seed–Growth

Check

$4.3M – $71M

Tokyo, JP

Instruments

Equity

Founded

2014

AUM

$200M

Team · 4 people

from the firm's website & public directories

Hans Yang（楊明勲）· Taipei

Spent 10 years in legal roles at a major Taiwanese manufacturer and VC before joining the firm; covered Hong Kong and China from 2010 executing investments and exits, then moved to Taiwan in 2014 to focus on Taiwanese biotech investment and sourcing.

Wei Fan Chen（陳威帆）· Taipei

Joined the firm in 2021 after five years of investing at major Taiwanese and biotech-focused VCs; focuses on Taiwanese startups in pharmaceuticals, medical devices, and healthcare services. Holds a PhD in pharmacy.

LingLing Liu（劉玲玲）· Tokyo

Joined DCIP in 2015 after working as a financial advisor in Daiwa Securities' M&A division.

Hiroki Narita· President and CEO

Frequently asked questions

What stage does DCI Partners Co. Ltd. invest at?: DCI Partners Co. Ltd. invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth stages.
What is DCI Partners Co. Ltd.'s typical check size?: DCI Partners Co. Ltd. typically writes checks of $4.3M – $71M.
What sectors does DCI Partners Co. Ltd. focus on?: DCI Partners Co. Ltd. focuses on Biotech, Digital Health, Healthtech, Medical Devices, SaaS, Sector Agnostic.
Where is DCI Partners Co. Ltd. located?: DCI Partners Co. Ltd. is headquartered in Tokyo, JP.

Images

Similar investors

B Capital Group

B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.

$10M – $50M

DCVC (Data Collective)

DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.

$5M – $25M

Innovestor Ventures

Innovestor is a Nordic investment group operating across venture capital, life science, real estate, energy storage, and corporate venturing platforms, and is among the most active early-stage investors in the region.

$270K – $3.2M

Khosla Ventures

Khosla Ventures is a venture capital firm known for backing bold, contrarian bets in world-class teams that can reshape entire industries.

$5K – $50M

Kleiner Perkins

Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, with a portfolio of companies from early stage through growth.

$500K – $15M